Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 15, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 17, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000875320-26-000247
Filed / recorded
Jul 17, 2026, 8:05 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
VERTEX PHARMACEUTICALS INC / MA
Issuer CIK
875320
Ticker
VRTX
Reporting person
Alan M Garber
Relationship
Director
Security
Deferred Stock Units
Table
Derivative (Table II)
Transaction date
Jul 15, 2026
Transaction code
A
Shares / units
31.56
Price per share
$475.28
Acquired / disposed
Acquired (A)
Shares owned after
65.458
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.
Congress trade